BiomX Inc.
PHGE
$4.56
$0.051.11%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 17.45% | 38.05% | 47.02% | 45.62% | 24.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.56% | 19.26% | 44.49% | 36.80% | 22.62% |
| Operating Income | -2.56% | -19.26% | -44.49% | -36.80% | -22.62% |
| Income Before Tax | -329.79% | 29.25% | 78.31% | 32.25% | 67.20% |
| Income Tax Expenses | -18.18% | -68.42% | -59.09% | -43.48% | -81.97% |
| Earnings from Continuing Operations | -329.35% | 29.28% | 78.30% | 32.26% | 67.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -329.35% | 29.28% | 78.30% | 32.26% | 67.23% |
| EBIT | -2.56% | -19.26% | -44.49% | -36.80% | -22.62% |
| EBITDA | 2.61% | -17.13% | -42.26% | -34.31% | -22.70% |
| EPS Basic | 21.25% | 72.41% | 99.06% | 64.33% | 68.47% |
| Normalized Basic EPS | 54.60% | 94.81% | 105.28% | 63.03% | 60.41% |
| EPS Diluted | 63.14% | 82.33% | 52.10% | 15.33% | 28.82% |
| Normalized Diluted EPS | 57.72% | 95.02% | 102.19% | 59.55% | 57.49% |
| Average Basic Shares Outstanding | 189.80% | 247.76% | 176.16% | 134.52% | 106.07% |
| Average Diluted Shares Outstanding | 137.97% | 166.37% | 209.42% | 172.68% | 150.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |